Information for "A phase I-II, open-label, multicenter trial to determine the dosimetry and safety of 99mTc-Sestamibi in pediatric subjects"
Basic information
| Display title | A phase I-II, open-label, multicenter trial to determine the dosimetry and safety of 99mTc-Sestamibi in pediatric subjects |
| Default sort key | A phase I-II, open-label, multicenter trial to determine the dosimetry and safety of 99mTc-Sestamibi in pediatric subjects |
| Page length (in bytes) | 551 |
| Page ID | 15086 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | 187.21.138.9 (talk) |
| Date of page creation | 08:49, 13 August 2022 |
| Latest editor | 187.21.138.9 (talk) |
| Date of latest edit | 08:49, 13 August 2022 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |